DECAF Score for Acute Exacerbation of COPD

The DECAF score predicts in‑hospital mortality in acute COPD exacerbations using five admission variables 1 [Level I evidence].

Extended MRC Dyspnea Scale (eMRCD)
Not too dyspneic to leave house (eMRCD 1-4)0Too dyspneic to leave house but independent w/ washing/dressing (eMRCD 5a)+1Too dyspneic to leave house and wash/dress (eMRCD 5b)+2
Eosinopenia
No0Yes+1
Consolidation on CXR
No0Yes+1
Acidemia
No0Yes+1
AFib
No0Yes+1

Indicaciones de Uso

Used for adults hospitalized with acute COPD exacerbation to predict in‑hospital and 30‑day mortality and to guide disposition.
Low scores (0–1) identify patients suitable for Hospital at Home/early supported discharge (validated non‑inferior RCT, 118 pts 1 [Level I evidence]).
Higher scores (≥3) indicate high short‑term mortality risk and need for closer monitoring or escalation (external validation AUROC 0.82–0.83; 1725 pts 2 [Level I evidence]).

Información y Precauciones

Stratifies inpatient mortality risk in AECOPD using five routinely available variables and shows strong discrimination (AUROC ~0.82–0.86) in large internal/external validations 1 [Level I evidence]; 2 [Level II evidence]. Low scores (0–1) reliably identify patients suitable for early supported or home-based care 3 [Level I evidence]. Avoid over-reliance in complex multimorbid or cardiovascular disease–driven presentations, where alternative models may outperform DECAF 4 [Level II evidence].